Elective surgery in patients with congenital coagulopathies and inhibitors: Experience of the National Haemophilia Centre of Venezuela

Haemophilia

Volumn 17, Issue 3, 2011, Pages 422-427

  Boadas, A ^a   Fernandez Palazzi F ^a   De Bosch, N B ^a   Cedeno M ^a   Ruiz Saez A ^a  

^a National Haemophilia Center   (Venezuela)

Author keywords

Bypassing agents; Inhibitors; Recombinant FVIIa; Surgery

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 CONCENTRATE; FIBRIN GLUE; GELFOAM; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CHILD; CLINICAL ARTICLE; ELECTIVE SURGERY; FEMALE; HEMOSTASIS; HUMAN; MAJOR SURGERY; MALE; MINOR SURGERY; PRIORITY JOURNAL; TREATMENT FAILURE; VENEZUELA;

ADOLESCENT; ADULT; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD LOSS, SURGICAL; CHILD; CHILD, PRESCHOOL; FACTOR VIIA; FEMALE; HEMOPHILIA A; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; MALE; RECOMBINANT PROTEINS; SURGICAL PROCEDURES, ELECTIVE; VON WILLEBRAND DISEASE, TYPE 3; YOUNG ADULT;

EID: 79955149091     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02427.x     Document Type: Article

References (37)

1. Hvid I, Soballe K, Ingerslev J. Elective orthopaedic surgery in haemophilia patients with high-responding inhibitors. In: Rodriguez-Merchan EC, Lee CA eds. Inhibitors in Patients with Haemophilia. Oxford, UK: Blackwell Science, 2002: 169-76.
2. Ingerslev J. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors. Semin Thromb Hemost 2000; 26: 425-32.
3. Rodriguez-Merchan EC. Some recent developments regarding arthropathy and inhibitors in haemophilia. Haemophilia 2008; 14: 242-7.
4. Morfini M, Haya S, Tagariello G et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia 2007; 13: 606-12.
5. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102: 2358-63.
6. Berntorp E. Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors. Haemophilia 2009; 15: 3-10.
7. Hanna WT, Madigan RR, Miles MA, Lange RD. Activated factor IX complex in treatment of surgical cases of hemophilia A with inhibitors. Thromb Haemost 1981; 46: 638-41.
8. Ingerslev J, Freidman D, Gastineau D et al. Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa. Haemostasis 1996; 26(Suppl. 1): 118-23.
9. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost 1997; 77: 1113-9.
10. Rodriguez-Merchan EC, Rocino A, Ewenstein B et al. Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement. Haemophilia 2004; 10(Suppl. 2): 50-2.
11. Obergfell A, Auvinen MK, Mathew P. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature. Haemophilia 2008; 14: 233-41.
12. Takedani H, Kawahara H, Kajiwara M. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa. Haemophilia 2010; 16: 290-5.
13. Teitel JM, Carcao M, Lillicrap D et al. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Haemophilia 2009; 15: 227-39.
14. Perez BR, Ozelo MC, Villaca PR et al. Diagnosis and treatment of congenital hemophilia with inhibitors a Latin American perspective. Medicina (B Aires) 2008; 68: 227-42.
15. Rickard KA. Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia 1995; 1: 8-13.
16. Quintana M, Bello IF, Yuste VJ et al. Orthopaedic surgery in two haemophilic patients with high-response inhibitors. J Thromb Haemost 2007; 5(Suppl. 2): P-W-145.
17. Lopez-Fernandez MF, Martin R, Lopez-Berges C, Ramos F, Bosch N, Batlle J. Further specificity characterization of von Willebrand factor inhibitors developed in two patients with severe von Willebrand disease. Blood 1988; 72: 116-20.
18. Lusher J, Ingerslev J, Roberts H, Hedner U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis 1998; 9: 119-28.
19. Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2004; 2: 899-909.
20. White B, Smith O. General and emergency surgery in patients with high-responding inhibitors in patients with haemophilia. In: Rodriguez-Merchan EC, Lee CA eds. Inhibitors in Patients with Haemophilia. Oxford, UK: Blackwell Science, 2002: 179-82.
21. Hedner U, Glazer S, Pingel K et al. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet 1988; 2: 1193.
22. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80: 773-8.
23. Mannucci PM, Franchini M, Castaman G, Federici AB. Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus 2009; 7: 117-26.
24. Giangrande PL, Wilde JT, Madan B et al. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia 2009; 15: 501-8.
25. Quintana-Molina M, Martinez-Bahamonde F, Gonzalez-Garcia E et al. Surgery in haemophilic patients with inhibitor: 20years of experience. Haemophilia 2004; 10(Suppl. 2): 30-40.
26. Schulman S. Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group. Haemophilia 1998; 4: 564-7.
27. Berntorp E. Options for treating acute bleeds in addition to bypassing agents: extracorporeal immunoadsorption, FVIII/FIX, desmopressin and antifibrinolytics. Haemophilia 2006; 12(Suppl. 6): 62-5.
28. Fernandez-Palazzi F, Rivas S, de Bosch NB, De Castro E, Quevedo M, Saez A. Percutaneous treatment of haemophilic cysts and pseudotumors. In: Lusher JM, Kessler CM eds. Hemophilia and von Willebrand's Disease in the 1990s. Amsterdam: Excerpta Medica, 1991: 157-64.
29. Fernandez-Palazzi F, Rivas S, Marulanda A, Boada A, de Saez AR, de Bosch NB. On two extensive surgeries of giant soft tissue haemophilic pseudotumors of the thigh (abstract). Presented at: The World Federation of Haemophilia 5th Musculo-skeletal Congress, April 1999; Sydney, Australia.
30. Tjonnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX. Haemophilia 2004; 10: 174-8.
31. Lauroua P, Ferrer AM, Guerin V. Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors. Haemophilia 2009; 15: 1300-7.
32. Negrier C. Inhibitors to factor VIII; treatment of acute bleeds. In: Lee CA, Berntorp E, Hoots WK eds. Text of Hemophilia. Malden, MA: Blackwell Publishing, 2005: 80-5.
33. Word Federation of Hemophilia. Guidelines for the Management of Hemophilia. World Federation of Hemophilia. Available at Accessed March 09, 2010).
34. Ludlam C. Identifying and managing inhibitor patients requiring orthopaedic surgery - the multidisciplinary team approach. Haemophilia 2005; 11(Suppl. 1): 7-10.
35. Young G, Ebbesen LS, Viuff D et al. Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial. Blood Coagul Fibrinolysis 2008; 19: 276-82.
36. Dargaud Y, Negrier C. Thrombin generation testing in haemophilia comprehensive care centres. Haemophilia 2010; 16: 223-30.
37. Jimenez-Yuste V, Rodriguez-Merchan EC, Alvarez MT, Quintana M, Fernandez I, Hernandez-Navarro F. Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors. Semin Hematol 2008; 45: S64-S67.